Logo image of ICL

ICL GROUP LTD (ICL) Stock Fundamental Analysis

NYSE:ICL - New York Stock Exchange, Inc. - IL0002810146 - Common Stock - Currency: USD

6.87  +0.12 (+1.78%)

After market: 6.87 0 (0%)

Fundamental Rating

5

Taking everything into account, ICL scores 5 out of 10 in our fundamental rating. ICL was compared to 85 industry peers in the Chemicals industry. ICL scores excellent on profitability, but there are some minor concerns on its financial health. ICL has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

ICL had positive earnings in the past year.
In the past year ICL had a positive cash flow from operations.
In the past 5 years ICL has always been profitable.
In the past 5 years ICL always reported a positive cash flow from operatings.
ICL Yearly Net Income VS EBIT VS OCF VS FCFICL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B

1.2 Ratios

Looking at the Return On Assets, with a value of 3.33%, ICL is in the better half of the industry, outperforming 65.88% of the companies in the same industry.
Looking at the Return On Equity, with a value of 6.66%, ICL is in the better half of the industry, outperforming 65.88% of the companies in the same industry.
With a decent Return On Invested Capital value of 5.98%, ICL is doing good in the industry, outperforming 62.35% of the companies in the same industry.
ICL had an Average Return On Invested Capital over the past 3 years of 13.86%. This is significantly above the industry average of 6.83%.
The last Return On Invested Capital (5.98%) for ICL is well below the 3 year average (13.86%), which needs to be investigated, but indicates that ICL had better years and this may not be a problem.
Industry RankSector Rank
ROA 3.33%
ROE 6.66%
ROIC 5.98%
ROA(3y)9.18%
ROA(5y)6.94%
ROE(3y)19.28%
ROE(5y)15.08%
ROIC(3y)13.86%
ROIC(5y)10.81%
ICL Yearly ROA, ROE, ROICICL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30

1.3 Margins

With a decent Profit Margin value of 5.66%, ICL is doing good in the industry, outperforming 70.59% of the companies in the same industry.
ICL's Profit Margin has declined in the last couple of years.
The Operating Margin of ICL (11.01%) is better than 61.18% of its industry peers.
In the last couple of years the Operating Margin of ICL has declined.
ICL's Gross Margin of 32.87% is fine compared to the rest of the industry. ICL outperforms 61.18% of its industry peers.
ICL's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 11.01%
PM (TTM) 5.66%
GM 32.87%
OM growth 3Y-13.01%
OM growth 5Y-4.18%
PM growth 3Y-19.15%
PM growth 5Y-7.97%
GM growth 3Y-4.23%
GM growth 5Y-0.88%
ICL Yearly Profit, Operating, Gross MarginsICL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30 40 50

4

2. Health

2.1 Basic Checks

ICL has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
Compared to 1 year ago, ICL has about the same amount of shares outstanding.
The number of shares outstanding for ICL has been increased compared to 5 years ago.
Compared to 1 year ago, ICL has an improved debt to assets ratio.
ICL Yearly Shares OutstandingICL Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B
ICL Yearly Total Debt VS Total AssetsICL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.2 Solvency

The Debt to FCF ratio of ICL is 4.07, which is a neutral value as it means it would take ICL, 4.07 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 4.07, ICL belongs to the top of the industry, outperforming 85.88% of the companies in the same industry.
ICL has a Debt/Equity ratio of 0.32. This is a healthy value indicating a solid balance between debt and equity.
ICL has a Debt to Equity ratio of 0.32. This is in the better half of the industry: ICL outperforms 72.94% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.32
Debt/FCF 4.07
Altman-Z N/A
ROIC/WACC0.76
WACC7.85%
ICL Yearly LT Debt VS Equity VS FCFICL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B 4B 5B

2.3 Liquidity

ICL has a Current Ratio of 1.47. This is a normal value and indicates that ICL is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of ICL (1.47) is worse than 69.41% of its industry peers.
ICL has a Quick Ratio of 1.47. This is a bad value and indicates that ICL is not financially healthy enough and could expect problems in meeting its short term obligations.
ICL has a worse Quick ratio (0.85) than 74.12% of its industry peers.
Industry RankSector Rank
Current Ratio 1.47
Quick Ratio 0.85
ICL Yearly Current Assets VS Current LiabilitesICL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

3

3. Growth

3.1 Past

ICL shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -11.63%.
Looking at the last year, ICL shows a decrease in Revenue. The Revenue has decreased by -3.48% in the last year.
Measured over the past years, ICL shows a small growth in Revenue. The Revenue has been growing by 5.35% on average per year.
EPS 1Y (TTM)-11.63%
EPS 3Y-16.38%
EPS 5Y0%
EPS Q2Q%0%
Revenue 1Y (TTM)-3.48%
Revenue growth 3Y-0.55%
Revenue growth 5Y5.35%
Sales Q2Q%1.84%

3.2 Future

The Earnings Per Share is expected to grow by 10.38% on average over the next years. This is quite good.
The Revenue is expected to grow by 3.04% on average over the next years.
EPS Next Y15.35%
EPS Next 2Y15.01%
EPS Next 3Y10.38%
EPS Next 5YN/A
Revenue Next Year2.39%
Revenue Next 2Y3.23%
Revenue Next 3Y3.04%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
ICL Yearly Revenue VS EstimatesICL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2B 4B 6B 8B 10B
ICL Yearly EPS VS EstimatesICL Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0.5 1 1.5

5

4. Valuation

4.1 Price/Earnings Ratio

ICL is valuated rather expensively with a Price/Earnings ratio of 18.08.
ICL's Price/Earnings ratio is in line with the industry average.
ICL's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 27.50.
A Price/Forward Earnings ratio of 13.67 indicates a correct valuation of ICL.
Based on the Price/Forward Earnings ratio, ICL is valued a bit cheaper than the industry average as 61.18% of the companies are valued more expensively.
ICL's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 36.44.
Industry RankSector Rank
PE 18.08
Fwd PE 13.67
ICL Price Earnings VS Forward Price EarningsICL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

ICL's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. ICL is cheaper than 74.12% of the companies in the same industry.
ICL's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. ICL is cheaper than 80.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF 14.88
EV/EBITDA 7.91
ICL Per share dataICL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3 4 5

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
ICL has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)1.18
PEG (5Y)N/A
EPS Next 2Y15.01%
EPS Next 3Y10.38%

3

5. Dividend

5.1 Amount

ICL has a Yearly Dividend Yield of 2.78%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 3.62, ICL pays a bit more dividend than its industry peers.
ICL's Dividend Yield is comparable with the S&P500 average which is at 2.34.
Industry RankSector Rank
Dividend Yield 2.78%

5.2 History

The dividend of ICL decreases each year by -1.81%.
ICL has been paying a dividend for at least 10 years, so it has a reliable track record.
Dividend Growth(5Y)-1.81%
Div Incr Years0
Div Non Decr Years0
ICL Yearly Dividends per shareICL Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1 2 3

5.3 Sustainability

62.21% of the earnings are spent on dividend by ICL. This is not a sustainable payout ratio.
DP62.21%
EPS Next 2Y15.01%
EPS Next 3Y10.38%
ICL Yearly Income VS Free CF VS DividendICL Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B 2B
ICL Dividend Payout.ICL Dividend Payout, showing the Payout Ratio.ICL Dividend Payout.PayoutRetained Earnings

ICL GROUP LTD

NYSE:ICL (7/18/2025, 8:04:00 PM)

After market: 6.87 0 (0%)

6.87

+0.12 (+1.78%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)05-19 2025-05-19/bmo
Earnings (Next)08-06 2025-08-06
Inst Owners23.58%
Inst Owner Change0%
Ins Owners0.1%
Ins Owner ChangeN/A
Market Cap8.87B
Analysts48.89
Price Target0.07 (-98.98%)
Short Float %0.27%
Short Ratio2.53
Dividend
Industry RankSector Rank
Dividend Yield 2.78%
Yearly Dividend0.19
Dividend Growth(5Y)-1.81%
DP62.21%
Div Incr Years0
Div Non Decr Years0
Ex-Date06-04 2025-06-04 (0.1502076)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-8.67%
Min EPS beat(2)-18.25%
Max EPS beat(2)0.9%
EPS beat(4)3
Avg EPS beat(4)6.19%
Min EPS beat(4)-18.25%
Max EPS beat(4)25.18%
EPS beat(8)6
Avg EPS beat(8)8.98%
EPS beat(12)8
Avg EPS beat(12)7.78%
EPS beat(16)12
Avg EPS beat(16)19.31%
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)4.35%
PT rev (3m)50.32%
EPS NQ rev (1m)9.46%
EPS NQ rev (3m)-8.47%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.42%
Valuation
Industry RankSector Rank
PE 18.08
Fwd PE 13.67
P/S 1.29
P/FCF 14.88
P/OCF 6.55
P/B 1.52
P/tB 1.8
EV/EBITDA 7.91
EPS(TTM)0.38
EY5.53%
EPS(NY)0.5
Fwd EY7.32%
FCF(TTM)0.46
FCFY6.72%
OCF(TTM)1.05
OCFY15.27%
SpS5.33
BVpS4.53
TBVpS3.82
PEG (NY)1.18
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 3.33%
ROE 6.66%
ROCE 8.33%
ROIC 5.98%
ROICexc 6.28%
ROICexgc 7.02%
OM 11.01%
PM (TTM) 5.66%
GM 32.87%
FCFM 8.67%
ROA(3y)9.18%
ROA(5y)6.94%
ROE(3y)19.28%
ROE(5y)15.08%
ROIC(3y)13.86%
ROIC(5y)10.81%
ROICexc(3y)14.67%
ROICexc(5y)11.45%
ROICexgc(3y)16.24%
ROICexgc(5y)12.7%
ROCE(3y)19.96%
ROCE(5y)15.59%
ROICexcg growth 3Y-15.7%
ROICexcg growth 5Y-1.81%
ROICexc growth 3Y-15.48%
ROICexc growth 5Y-2.08%
OM growth 3Y-13.01%
OM growth 5Y-4.18%
PM growth 3Y-19.15%
PM growth 5Y-7.97%
GM growth 3Y-4.23%
GM growth 5Y-0.88%
F-Score4
Asset Turnover0.59
Health
Industry RankSector Rank
Debt/Equity 0.32
Debt/FCF 4.07
Debt/EBITDA 1.37
Cap/Depr 126.33%
Cap/Sales 11.03%
Interest Coverage 6.06
Cash Conversion 99.78%
Profit Quality 153.21%
Current Ratio 1.47
Quick Ratio 0.85
Altman-Z N/A
F-Score4
WACC7.85%
ROIC/WACC0.76
Cap/Depr(3y)138.38%
Cap/Depr(5y)133.57%
Cap/Sales(3y)9.41%
Cap/Sales(5y)9.89%
Profit Quality(3y)123.56%
Profit Quality(5y)409.37%
High Growth Momentum
Growth
EPS 1Y (TTM)-11.63%
EPS 3Y-16.38%
EPS 5Y0%
EPS Q2Q%0%
EPS Next Y15.35%
EPS Next 2Y15.01%
EPS Next 3Y10.38%
EPS Next 5YN/A
Revenue 1Y (TTM)-3.48%
Revenue growth 3Y-0.55%
Revenue growth 5Y5.35%
Sales Q2Q%1.84%
Revenue Next Year2.39%
Revenue Next 2Y3.23%
Revenue Next 3Y3.04%
Revenue Next 5YN/A
EBIT growth 1Y-13.88%
EBIT growth 3Y-13.49%
EBIT growth 5Y0.95%
EBIT Next Year73.14%
EBIT Next 3Y23.84%
EBIT Next 5YN/A
FCF growth 1Y-54.22%
FCF growth 3Y18.48%
FCF growth 5Y12.66%
OCF growth 1Y-34.97%
OCF growth 3Y11.29%
OCF growth 5Y8.15%